could you disclose more, please?
APD371, an orally available agonist of the CB2 receptor, is an internally discovered investigational drug candidate that Arena is exploring for potential development in several indications, including pain. This compound, through its selectivity, is designed to provide pain relief without psychotropic effects and without the potential for dependence or abuse.
Supposed to be more powerful than morphine according to stuff I’ve read.
More info at www.arenapharma.com
Full disclosure I’m a long suffering underwater shareholder.